The company conducts basic research and clinical research in the fields of tissue engineering, cell biology, and the development and implementation of matrix carriers for functional mini-organs. Furthermore, the company aims to manage medical practices with all related medical and administrative services in the field of abdominal medicine and adjacent specialties such as general surgery, visceral surgery, gastroenterology, internal medicine, and oncology. The company can enter into any business and conclude contracts that are suitable to promote the purpose of the company or are directly or indirectly related to it. The company can acquire, encumber, manage, and dispose of securities. It can acquire, manage, and exploit intellectual property rights. The company can acquire, encumber, sell, and manage real estate in Switzerland and abroad. It can also provide financing for its own account or for third-party accounts, as well as provide guarantees and sureties for subsidiaries and third parties. Additionally, it can establish branches and subsidiaries in Switzerland and abroad, participate in other companies, or merge with them.